drugset / Trial / NCT01276977
Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to Compare the efficacy of zolmitriptan 5 mg nasal spray vs. eletriptan 40 mg tablet in the acute treatment of migraine. To develop and evaluate a set of importance weights for a predefined set of treatment attributes for migraine suffers using zolmitriptan 5 mg nasal spray vs. eletriptan 40 mg tablet. To contrast the efficacy of zolmitriptan 5 mg nasal spray vs. eletriptan 40 mg tablet at early time points. To analyze the patterns of self-reported tolerability of migraine sufferers using zolmitriptan 5 mg nasal spray vs. eletriptan 40 mg tablet.
Timeline
- Start
- 2008-04
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eletriptan | Small molecule | 40 mg | — |
| Subject | Zolmitriptan | Small molecule | 5 mg | Intranasal |